Inflammasome activation in infected macrophages drives COVID-19 pathology

Nature. 2022 Jun;606(7914):585-593. doi: 10.1038/s41586-022-04802-1. Epub 2022 Apr 28.

Abstract

Severe COVID-19 is characterized by persistent lung inflammation, inflammatory cytokine production, viral RNA and a sustained interferon (IFN) response, all of which are recapitulated and required for pathology in the SARS-CoV-2-infected MISTRG6-hACE2 humanized mouse model of COVID-19, which has a human immune system1-20. Blocking either viral replication with remdesivir21-23 or the downstream IFN-stimulated cascade with anti-IFNAR2 antibodies in vivo in the chronic stages of disease attenuates the overactive immune inflammatory response, especially inflammatory macrophages. Here we show that SARS-CoV-2 infection and replication in lung-resident human macrophages is a critical driver of disease. In response to infection mediated by CD16 and ACE2 receptors, human macrophages activate inflammasomes, release interleukin 1 (IL-1) and IL-18, and undergo pyroptosis, thereby contributing to the hyperinflammatory state of the lungs. Inflammasome activation and the accompanying inflammatory response are necessary for lung inflammation, as inhibition of the NLRP3 inflammasome pathway reverses chronic lung pathology. Notably, this blockade of inflammasome activation leads to the release of infectious virus by the infected macrophages. Thus, inflammasomes oppose host infection by SARS-CoV-2 through the production of inflammatory cytokines and suicide by pyroptosis to prevent a productive viral cycle.

MeSH terms

  • Angiotensin-Converting Enzyme 2
  • Animals
  • COVID-19* / pathology
  • COVID-19* / physiopathology
  • COVID-19* / virology
  • Humans
  • Inflammasomes* / metabolism
  • Interleukin-1
  • Interleukin-18
  • Lung / pathology
  • Lung / virology
  • Macrophages* / metabolism
  • Macrophages* / pathology
  • Macrophages* / virology
  • Mice
  • NLR Family, Pyrin Domain-Containing 3 Protein / metabolism
  • Pneumonia / metabolism
  • Pneumonia / virology
  • Pyroptosis
  • Receptors, IgG
  • SARS-CoV-2* / metabolism
  • SARS-CoV-2* / pathogenicity

Substances

  • Inflammasomes
  • Interleukin-1
  • Interleukin-18
  • NLR Family, Pyrin Domain-Containing 3 Protein
  • Receptors, IgG
  • Angiotensin-Converting Enzyme 2